ITMI991860A0 - Derivati di acidi 2-ammino-biciclo(3.1.0)-esan-2,6-bicarbossilici e pr ocedimento per la loro preparazione - Google Patents

Derivati di acidi 2-ammino-biciclo(3.1.0)-esan-2,6-bicarbossilici e pr ocedimento per la loro preparazione

Info

Publication number
ITMI991860A0
ITMI991860A0 IT99MI001860A ITMI991860A ITMI991860A0 IT MI991860 A0 ITMI991860 A0 IT MI991860A0 IT 99MI001860 A IT99MI001860 A IT 99MI001860A IT MI991860 A ITMI991860 A IT MI991860A IT MI991860 A0 ITMI991860 A0 IT MI991860A0
Authority
IT
Italy
Prior art keywords
biciclo
hexane
derivatives
amino
procedure
Prior art date
Application number
IT99MI001860A
Other languages
English (en)
Inventor
Adam Geo
Philippe Nic Huguenin-Virchaux
Vincent Mutel
Heinz Stadler
Thomas Johannes Woltering
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of ITMI991860A0 publication Critical patent/ITMI991860A0/it
Publication of ITMI991860A1 publication Critical patent/ITMI991860A1/it
Application granted granted Critical
Publication of IT1313618B1 publication Critical patent/IT1313618B1/it

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/30Preparation of optical isomers
    • C07C227/32Preparation of optical isomers by stereospecific synthesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/46Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C229/50Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups and carboxyl groups bound to carbon atoms being part of the same condensed ring system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C247/00Compounds containing azido groups
    • C07C247/14Compounds containing azido groups with azido groups bound to carbon atoms of rings other than six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/05Isotopically modified compounds, e.g. labelled
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/14All rings being cycloaliphatic
    • C07C2602/18All rings being cycloaliphatic the ring system containing six carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cephalosporin Compounds (AREA)
IT1999MI001860A 1998-09-03 1999-09-01 Derivati di acidi 2-ammino-biciclo(3.1.0)-esan-2,6-bicarbossilici eprocedimento per la loro preparazione. IT1313618B1 (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98116670 1998-09-03

Publications (3)

Publication Number Publication Date
ITMI991860A0 true ITMI991860A0 (it) 1999-09-01
ITMI991860A1 ITMI991860A1 (it) 2001-03-01
IT1313618B1 IT1313618B1 (it) 2002-09-09

Family

ID=8232576

Family Applications (1)

Application Number Title Priority Date Filing Date
IT1999MI001860A IT1313618B1 (it) 1998-09-03 1999-09-01 Derivati di acidi 2-ammino-biciclo(3.1.0)-esan-2,6-bicarbossilici eprocedimento per la loro preparazione.

Country Status (13)

Country Link
US (1) US6107342A (it)
JP (1) JP3340409B2 (it)
AT (1) AT501853B1 (it)
AU (1) AU757939B2 (it)
BE (1) BE1014616A3 (it)
CA (1) CA2281272C (it)
CH (1) CH694053A5 (it)
DE (1) DE19941675B4 (it)
FR (1) FR2786768B1 (it)
GB (1) GB2341179B (it)
IT (1) IT1313618B1 (it)
NL (1) NL1012963C2 (it)
SE (1) SE520026C2 (it)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1459765B1 (en) * 2001-12-27 2008-08-20 Taisho Pharmaceutical Co., Ltd 6-fluorobicyclo 3.1.0 hexane derivatives
JP2007063129A (ja) * 2003-06-26 2007-03-15 Taisho Pharmaceut Co Ltd 2−アミノ−3−アルコキシビシクロ[3.1.0]ヘキサン誘導体
CN100582087C (zh) 2003-06-26 2010-01-20 大正制药株式会社 2-氨基-双环[3.1.0]己烷-2,6-二甲酸酯衍生物
JP4792971B2 (ja) 2003-06-26 2011-10-12 大正製薬株式会社 2−アミノ−ビシクロ[3.1.0]ヘキサン−2,6−ジカルボン酸エステル誘導体
JP4984529B2 (ja) * 2003-06-26 2012-07-25 大正製薬株式会社 2−アミノビシクロ[3.1.0]ヘキサン−2,6−ジカルボン酸誘導体
US7301003B2 (en) * 2005-08-26 2007-11-27 Enzon Pharmaceuticals, Inc. Method of preparing polymers having terminal amine groups
EP2258358A3 (en) 2005-08-26 2011-09-07 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
US7678363B2 (en) 2005-08-26 2010-03-16 Braincells Inc Methods of treating psychiatric conditions comprising administration of muscarinic agents in combination with SSRIs
EP1940389A2 (en) 2005-10-21 2008-07-09 Braincells, Inc. Modulation of neurogenesis by pde inhibition
US20070112017A1 (en) 2005-10-31 2007-05-17 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
AR059898A1 (es) 2006-03-15 2008-05-07 Janssen Pharmaceutica Nv Derivados de 3-ciano-piridona 1,4-disustituida y su uso como moduladores alostericos de los receptores mglur2
MX2008014320A (es) 2006-05-09 2009-03-25 Braincells Inc Neurogenesis mediada por el receptor de 5-hidroxitriptamina.
AU2007249399A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
JP2010502722A (ja) 2006-09-08 2010-01-28 ブレインセルス,インコーポレイティド 4−アシルアミノピリジン誘導体を含む組み合わせ
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
TW200900065A (en) 2007-03-07 2009-01-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
TW200845978A (en) * 2007-03-07 2008-12-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
CN101801930B (zh) * 2007-09-14 2013-01-30 奥梅-杨森制药有限公司 1,3-二取代的-4-苯基-1h-吡啶-2-酮
AU2008297876B2 (en) 2007-09-14 2011-07-07 Addex Pharma S.A. 1,3-disubstituted 4-(aryl-x-phenyl)-1h-pyridin-2-ones
BRPI0816767B8 (pt) 2007-09-14 2021-05-25 Addex Pharmaceuticals Sa composto 4-fenil-3,4,5,6-tetra-hidro-2h,1'h-[1,4']bipiridi¬nil-2'-onas 1',3'-dissubstituídas, composição farmacêutica e uso dos mesmos
ES2637794T3 (es) * 2007-11-14 2017-10-17 Janssen Pharmaceuticals, Inc. Derivados de imidazo[1,2-A]piridina y su uso como moduladores alostéricos positivos de receptores MGLUR2
AU2009289784B2 (en) 2008-09-02 2012-03-22 Addex Pharma S.A. 3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors
WO2010043396A1 (en) 2008-10-16 2010-04-22 Ortho-Mcneil-Janssen Pharmaceuticals, Inc. Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors
WO2010060589A1 (en) 2008-11-28 2010-06-03 Ortho-Mcneil-Janssen Pharmaceuticals, Inc. Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
MY153913A (en) 2009-05-12 2015-04-15 Janssen Pharmaceuticals Inc 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
US8946205B2 (en) 2009-05-12 2015-02-03 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
MY161325A (en) 2009-05-12 2017-04-14 Janssen Pharmaceuticals Inc 1, 2, 4-triazolo[4,3-a]pyridine derivatives and their use for the treatment or prevention of neurological and psychiatric disorders
PL2649069T3 (pl) 2010-11-08 2016-01-29 Janssen Pharmaceuticals Inc Pochodne 1,2,4-triazolo[4,3-a]pirydyny i ich zastosowanie jako dodatnich allosterycznych modulatorów receptorów mGluR2
AU2011328203B2 (en) 2010-11-08 2015-03-19 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
CN103261195B (zh) 2010-11-08 2015-09-02 杨森制药公司 1,2,4-三唑并[4,3-a]吡啶衍生物及其作为MGLUR2受体的正变构调节剂的用途
MX2013005623A (es) * 2010-11-18 2013-07-05 Lilly Co Eli Compuestos de 3-benciloxi-biciclico [3.1.0] hexano 4-sustituidos como antagonistas de mglur 2/3.
TWI520935B (zh) 2010-11-18 2016-02-11 美國禮來大藥廠 作為mGluR2/3拮抗劑之4-經取代-3-苯基磺醯基甲基-雙環[3.1.0]己烷化合物
JO3368B1 (ar) 2013-06-04 2019-03-13 Janssen Pharmaceutica Nv مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
JO3367B1 (ar) 2013-09-06 2019-03-13 Janssen Pharmaceutica Nv مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
KR102461134B1 (ko) 2014-01-21 2022-10-28 얀센 파마슈티카 엔.브이. 대사 조절형 글루탐산 작동성 수용체 제2아형의 양성 알로스테릭 조절제 또는 오르토스테릭 작동제를 포함하는 조합 및 그 용도
UA121965C2 (uk) 2014-01-21 2020-08-25 Янссен Фармацевтика Нв Комбінації, які містять позитивні алостеричні модулятори або ортостеричні агоністи метаботропного глутаматергічного рецептора 2 підтипу, та їх застосування

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5321143A (en) * 1988-05-26 1994-06-14 Massachusetts Institute Of Technology Ruthenium-catalyzed production of cyclic sulfates
PL182285B1 (pl) * 1994-08-12 2001-12-31 Lilly Co Eli Syntetyczne aminokwasy oraz ich estry i srodki farmaceutyczne je zawierajace PL PL PL PL PL PL PL
IL118727A (en) * 1995-06-29 2003-01-12 Lilly Co Eli (-)-2-spiro-5-hydantoinbicyclo [3.1.0] hexane-6-carboxylic acid, salts thereof and use thereof for the preparation of (+)-(2) aminobicyclo [3.1.0] hexane-2,6-dicarboxylic acid
WO1997017950A1 (en) * 1995-11-16 1997-05-22 Eli Lilly And Company Shoulder prosthesis

Also Published As

Publication number Publication date
GB2341179A (en) 2000-03-08
DE19941675A1 (de) 2000-03-09
ITMI991860A1 (it) 2001-03-01
AU757939B2 (en) 2003-03-13
CH694053A5 (de) 2004-06-30
AU4732799A (en) 2000-03-16
AT501853A1 (de) 2006-11-15
CA2281272C (en) 2011-01-04
JP2000086597A (ja) 2000-03-28
NL1012963C2 (nl) 2003-10-23
CA2281272A1 (en) 2000-03-03
GB9920579D0 (en) 1999-11-03
US6107342A (en) 2000-08-22
FR2786768A1 (fr) 2000-06-09
IE990737A1 (en) 2000-03-22
SE520026C2 (sv) 2003-05-13
BE1014616A3 (fr) 2004-02-03
AT501853B1 (de) 2010-06-15
NL1012963A1 (nl) 2000-03-06
IT1313618B1 (it) 2002-09-09
GB2341179B (en) 2004-02-18
SE9903088L (sv) 2000-03-04
FR2786768B1 (fr) 2004-10-15
SE9903088D0 (sv) 1999-09-01
DE19941675B4 (de) 2013-01-17
JP3340409B2 (ja) 2002-11-05

Similar Documents

Publication Publication Date Title
ITMI991860A0 (it) Derivati di acidi 2-ammino-biciclo(3.1.0)-esan-2,6-bicarbossilici e pr ocedimento per la loro preparazione
IT1311994B1 (it) Derivati di amminoacidi.
PT925298E (pt) Derivados 6,6-hetero-biciclicos substituidos
NO20011214D0 (no) FremgangsmÕte for fremstilling av aromatiske aldehyder
NO20030844L (no) Fremgangsmåte for fremstilling av N-aryl-antranilinsyrer og derivater derav
IT1206112B (it) Nuovi derivati di acidi biliari, procedimento per la loro preparazione e relative composizioni farmaceutiche.
IT8322572A0 (it) Derivati di acidi biliari, procedimento per la loro preparazione e relative composizioni farmaceutiche.
ITTO930346A0 (it) Procedimento per la preparazione di derivati taurocolanici.
IT8424187A0 (it) Derivati di acidi biliari, procedimento per la loro preparazione e relative composizioni farmaceutiche.
NO20024060L (no) Fremgangsmåte for fremstilling av et oksazolyletanolderivat
HUP9900344A3 (en) Process for the preparation of an optically active indoline-2-carboxylic acid or derivative thereof
TR199800403A3 (tr) a-Bromo-laktam türevlerinin hazirlanmasi için yöntem.
IT1305273B1 (it) Impianto e procedimento perfezionati per la produzione dipreforme multistrato.
NO985535L (no) FremgangsmÕte for fremstilling av 1,3-alkandioler
DE69913635D1 (de) Verfahren zur Herstellung von 1,3-Dialkyl-2-Imidazolinonderivaten
TR199800068A3 (tr) Benzofenon türevlerinin hazirlanmasina yönelik metodlar.
IT1307976B1 (it) Processo per la preparazione di acidi benzofenonsolfonici.
IT1312536B1 (it) Procedimento per la produzione e purificazione di acidi aromatici.
ITMI940802A0 (it) Procedimento per la preparazione di derivati di 5.6 diidrossi-2-ammino-1,2,3,4- tetraidronaftalene
DK1413575T3 (da) Fremgangsmåde til fremstilling af derivater af (1,5-diaryl)pyrazol-3-ylpropansyre
NO20012811D0 (no) Fremgangsmåte for fremstilling av p-klorfenyl-propanol- derivat
NO20013044L (no) Fremgangsmåte for fremstilling av NG-substituerte deaza- adenosinderivater
NO20005743L (no) Fremgangsmåte til fremstilling av 4,5-epoksymorfinan-6- glukuronider
ITMI972622A1 (it) Derivati del 2-fenilazulene e metodo per la produzione di questi composti
IT1284080B1 (it) Derivati ossaindenici e procedimento per la loro preparazione